Effectiveness and safety of adalimumab to treat outpatient ulcerative colitis: A real-life multicenter, observational study in primary inflammatory bowel disease centers

Adalimumab (ADA) was approved in Italy for the treatment of ulcerative colitis (UC) unresponsive to standard treatments in 2014, but no data from real life are currently available. The aim of the present study was to assess the real-life efficacy and safety of ADA in managing UC outpatients in some...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Medicine (Baltimore)
Main Authors: Tursi, Antonio, Elisei, Walter, Faggiani, Roberto, Allegretta, Leonardo, Valle, Nicola Della, Forti, Giacomo, Franceschi, Marilisa, Ferronato, Antonio, Gallina, Sara, Larussa, Tiziana, Luzza, Francesco, Lorenzetti, Roberto, Mocci, Giammarco, Penna, Antonio, Rodino’, Stefano, Sebkova, Ladislava, de Medici, Antonio, Pranzo, Giuseppe, Ricciardelli, Cristina, Grasso, Giuseppina, Scorza, Stefano, Zampaletta, Costantino, Picchio, Marcello
Formato: Artigo
Idioma:Inglês
Publicado em: Wolters Kluwer Health 2018
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6112877/
https://ncbi.nlm.nih.gov/pubmed/30142791
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000011897
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados